AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL

NIH RePORTER · NIH · N01 · $177,135 · view on reporter.nih.gov ↗

Abstract

AZA-TDC CAPSULES FOR USE IN CLINICAL TRIAL FOR POSSIBLE CANCER TREATMENT. THE DRUG PRODUCT (DP) WILL BE A 4 MG STRENGTH CAPSULE WHICH IS NOT AVAILABLE

Key facts

NIH application ID: 10710313
Project number: 75N98019D00058-0-759102200001-1
Recipient: IRISYS, INC.
Principal Investigator: ROBERT GIANNINI
Activity code: N01
Funding institute: NIH
Fiscal year: 2022
Award amount: $177,135
Award type: —
Project period: 2021-11-19 → 2025-11-18